Discover how Legend Biotech's robust Q1 performance and strategic initiatives are setting the stage for sustained growth.
Q1 2024 Legend Biotech Corp Earnings Call
SOMERSET, N.J., May 13, 2024--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its first quarter 2024 unaudited financial results and key corporate highlights.